The Board denied a higher rating for prostate cancer residuals and granted an effective date of January 26, 2021, for the grant of TDIU and DEA.
The deciding factor: The Veteran's prostate cancer residuals did not meet the criteria for a higher rating, but he was entitled to earlier effective dates for TDIU and DEA due to continuous pursuit of these benefits as part of his increased rating claim.
- Claimed conditions
- prostate cancer residuals
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- April 17, 2025
- Citation
- A25035610
What this means for you
A partial grant means some issues were granted while others were denied or remanded — common in multi-issue claims. Look at which issues went which way, and how each was argued.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board granted a 40 percent evaluation for prostate cancer residuals from January 29, 2014 to August 12, 2021.
- Denied
The Board denied the Veteran's claim for a total disability rating based on individual unemployability (TDIU) due to his service-connected disabilities, including prostate cancer residuals, hearing loss, tinnitus, and erectile dysfunction.
- Dismissed
The appeal of a proposal to reduce the rating for service-connected prostate cancer residuals from 100 percent to 40 percent is dismissed as it was not a final decision.
- Granted
The Veteran's prostate cancer residuals are granted a 60 percent rating from July 7, 2023.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.